NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain

RecruitingN/A

Sponsor: Boston Scientific Corporation

Conditions: Chronic Low-back Pain, Vertebrogenic Pain Syndrome

Interventions: Intracept™ Intraosseous Nerve Ablation

Countries: United States

Compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Study candidate is scheduled to be treated with a commercially approved Intracept™ Intraosseous Nerve Ablation System per local Instructions for Use (IFU).
* Signed a valid, IRB/EC-approved informed consent form.

Exclusion Criteria:

* Meets any contraindications per locally applicable Instructions for Use (IFU).

Locations (19)

Flagstaff, Arizona, United States
Phoenix, Arizona, United States
Larkspur, California, United States
Westport, Connecticut, United States
Washington D.C., District of Columbia, United States
Orlando, Florida, United States
Jasper, Georgia, United States
Post Falls, Idaho, United States
Barrington, Illinois, United States
Lexington, Kentucky, United States
New Orleans, Louisiana, United States
Maple Grove, Minnesota, United States
Port Jefferson Station, New York, United States
Rochester, New York, United States
Bermuda Run, North Carolina, United States
Eugene, Oregon, United States
Pittsburgh, Pennsylvania, United States
Houston, Texas, United States
Salt Lake City, Utah, United States